Tajuddin Sabir Shaikh
Director of Finance/CFO bei Emcure Pharmaceuticals Ltd.
Profil
Tajuddin Sabir Shaikh is currently a Director at Emcure Pharma UK Ltd.
He previously worked as the Chief Financial Officer at Emcure Pharmaceuticals Ltd.
starting in 2003.
Tajuddin is also a Member of The Institute of Chartered Accountants of India and The Institute of Cost & Works Accountants of India.
Additionally, he worked as a Director at Gennova Biopharmaceuticals Ltd.
in the past.
Aktive Positionen von Tajuddin Sabir Shaikh
Unternehmen | Position | Beginn |
---|---|---|
Emcure Pharma UK Ltd.
Emcure Pharma UK Ltd. Medical DistributorsDistribution Services Part of Emcure Pharmaceuticals Ltd., Emcure Pharma UK Ltd. is a wholesaler of pharmaceutical products. The private company is based in Luton, UK. | Director/Board Member | - |
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Director of Finance/CFO | 01.10.2003 |
The Institute of Chartered Accountants of India | Corporate Officer/Principal | - |
The Institute of Cost & Works Accountants of India | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Tajuddin Sabir Shaikh
Unternehmen | Position | Ende |
---|---|---|
Gennova Biopharmaceuticals Ltd.
Gennova Biopharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Gennova Biopharmaceuticals Ltd. specializes in biotechnology research for biosmiliars, vaccines, and mAbs using recombinant DNA technology. The company was founded on June 19, 2001 and is headquartered in Pune, India. | Director/Board Member | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
Gennova Biopharmaceuticals Ltd.
Gennova Biopharmaceuticals Ltd. Miscellaneous Commercial ServicesCommercial Services Gennova Biopharmaceuticals Ltd. specializes in biotechnology research for biosmiliars, vaccines, and mAbs using recombinant DNA technology. The company was founded on June 19, 2001 and is headquartered in Pune, India. | Commercial Services |
Emcure Pharma UK Ltd.
Emcure Pharma UK Ltd. Medical DistributorsDistribution Services Part of Emcure Pharmaceuticals Ltd., Emcure Pharma UK Ltd. is a wholesaler of pharmaceutical products. The private company is based in Luton, UK. | Distribution Services |